Luigi Naldini、Pierluigi Paracchi、Bernhard Gentner
The SDF-1:CXCR4 Axis | Non-Viral Gene Therapy。 |
JVS-100 (SDF-1)。 |
融资轮次 | 融资日期 | 投资方 | 融资额度 |
---|---|---|---|
Seed | 2008-09 | 未披露 | $300k |
Series A | 2008-10 | 未披露 | $7.72M |
Series B | 2012-07 | Triathlon Medical Venture Partners,New Science Ventures | $22.2M |
Venture | 2013-11 | 未披露 | $5M |
Series B | 2015-05 | POSCO Venture Capital,Green Cross | $13.5M |